Logo image of ALMCE.PA

MON COURTIER ENERGIE GROUPE (ALMCE.PA) Stock Fundamental Analysis

EPA:ALMCE - FR001400H3A0 - Common Stock

5.95 EUR
0 (0%)
Last: 9/4/2025, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to ALMCE. ALMCE was compared to 21 industry peers in the Independent Power and Renewable Electricity Producers industry. While ALMCE seems to be doing ok healthwise, there are quite some concerns on its profitability. ALMCE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

ALMCE had negative earnings in the past year.
In the past year ALMCE had a positive cash flow from operations.
ALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFALMCE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 1M 2M

1.2 Ratios

With a Return On Assets value of -1.10%, ALMCE is not doing good in the industry: 80.95% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -2.30%, ALMCE is doing worse than 76.19% of the companies in the same industry.
Industry RankSector Rank
ROA -1.1%
ROE -2.3%
ROIC N/A
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMCE.PA Yearly ROA, ROE, ROICALMCE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

Looking at the Gross Margin, with a value of 26.46%, ALMCE is in line with its industry, outperforming 42.86% of the companies in the same industry.
ALMCE's Gross Margin has been stable in the last couple of years.
ALMCE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
ALMCE.PA Yearly Profit, Operating, Gross MarginsALMCE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20 30

6

2. Health

2.1 Basic Checks

ALMCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALMCE remains at a similar level compared to 1 year ago.
ALMCE has a worse debt/assets ratio than last year.
ALMCE.PA Yearly Shares OutstandingALMCE.PA Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 1M 2M 3M
ALMCE.PA Yearly Total Debt VS Total AssetsALMCE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M 20M

2.2 Solvency

An Altman-Z score of 2.87 indicates that ALMCE is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of ALMCE (2.87) is better than 71.43% of its industry peers.
ALMCE has a debt to FCF ratio of 2.76. This is a good value and a sign of high solvency as ALMCE would need 2.76 years to pay back of all of its debts.
ALMCE has a Debt to FCF ratio of 2.76. This is amongst the best in the industry. ALMCE outperforms 95.24% of its industry peers.
ALMCE has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
With an excellent Debt to Equity ratio value of 0.00, ALMCE belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Altman-Z 2.87
ROIC/WACCN/A
WACC7.77%
ALMCE.PA Yearly LT Debt VS Equity VS FCFALMCE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

ALMCE has a Current Ratio of 1.80. This is a normal value and indicates that ALMCE is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ALMCE (1.80) is better than 71.43% of its industry peers.
ALMCE has a Quick Ratio of 1.80. This is a normal value and indicates that ALMCE is financially healthy and should not expect problems in meeting its short term obligations.
ALMCE has a Quick ratio of 1.80. This is in the better half of the industry: ALMCE outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.8
ALMCE.PA Yearly Current Assets VS Current LiabilitesALMCE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

6

3. Growth

3.1 Past

ALMCE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -117.71%.
ALMCE shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 17.25%.
The Revenue has been growing by 36.13% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-117.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.51%
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%

3.2 Future

Based on estimates for the next years, ALMCE will show a very strong growth in Earnings Per Share. The EPS will grow by 55.85% on average per year.
ALMCE is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.21% yearly.
EPS Next Y221.43%
EPS Next 2Y94.57%
EPS Next 3Y55.85%
EPS Next 5YN/A
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALMCE.PA Yearly Revenue VS EstimatesALMCE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
ALMCE.PA Yearly EPS VS EstimatesALMCE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4 0.5

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMCE. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 12.84 indicates a correct valuation of ALMCE.
61.90% of the companies in the same industry are more expensive than ALMCE, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of ALMCE to the average of the S&P500 Index (22.63), we can say ALMCE is valued slightly cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.84
ALMCE.PA Price Earnings VS Forward Price EarningsALMCE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50

4.2 Price Multiples

66.67% of the companies in the same industry are cheaper than ALMCE, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, ALMCE is valued a bit cheaper than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 70.93
EV/EBITDA 33.17
ALMCE.PA Per share dataALMCE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALMCE's earnings are expected to grow with 55.85% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y94.57%
EPS Next 3Y55.85%

0

5. Dividend

5.1 Amount

ALMCE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

MON COURTIER ENERGIE GROUPE

EPA:ALMCE (9/4/2025, 7:00:00 PM)

5.95

0 (0%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap21.78M
Analysts84.44
Price Target6.94 (16.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.33
Dividend Growth(5Y)N/A
DP-530%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.62%
PT rev (3m)4.62%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)542.86%
EPS NY rev (3m)542.86%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)5.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.84
P/S 0.88
P/FCF 70.93
P/OCF 30.72
P/B 2.18
P/tB 4.08
EV/EBITDA 33.17
EPS(TTM)-0.06
EYN/A
EPS(NY)0.46
Fwd EY7.79%
FCF(TTM)0.08
FCFY1.41%
OCF(TTM)0.19
OCFY3.26%
SpS6.74
BVpS2.73
TBVpS1.46
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.1%
ROE -2.3%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.46%
FCFM 1.24%
ROA(3y)8.1%
ROA(5y)N/A
ROE(3y)15.86%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.02%
GM growth 5YN/A
F-Score5
Asset Turnover1.18
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 2.76
Debt/EBITDA 0.01
Cap/Depr 80.72%
Cap/Sales 1.63%
Interest Coverage N/A
Cash Conversion 158.61%
Profit Quality N/A
Current Ratio 1.8
Quick Ratio 1.8
Altman-Z 2.87
F-Score5
WACC7.77%
ROIC/WACCN/A
Cap/Depr(3y)39.27%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.73%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-117.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-91.51%
EPS Next Y221.43%
EPS Next 2Y94.57%
EPS Next 3Y55.85%
EPS Next 5YN/A
Revenue 1Y (TTM)17.25%
Revenue growth 3Y36.13%
Revenue growth 5YN/A
Sales Q2Q%21.26%
Revenue Next Year14.98%
Revenue Next 2Y14.88%
Revenue Next 3Y12.21%
Revenue Next 5YN/A
EBIT growth 1Y-103.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y149.84%
FCF growth 3Y-48.05%
FCF growth 5YN/A
OCF growth 1Y231.05%
OCF growth 3Y-31.54%
OCF growth 5YN/A